N@N

ANGIODYNAMICS INC (NASDAQ:ANGO), Up By 6.22% ($0.95) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, April 19th 201

^{Published on 2011-04-26 09:31:23 - WOPRAI}
 

April 26, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, released a report on Tuesday, April 19th 2011 at 05:16:00 PDT stating that ANGIODYNAMICS INC (NASDAQ:ANGO) was expected to be Up After it crossed above its SqueezeTrigger Price of 15.23 on Tuesday, April 19th 2011. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=ango&id=161490

From August 2009 to March 2011, an aggregate amount of 11763610 shares of ANGO have been shorted for a total dollar value of $176454150. The ANGO SqueezeTrigger price of $15.23 is the volume weighted average price that all shorts are short in shares of ANGO. There is still approximately $13,270,992 of potential short covering in shares of ANGO.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com .

ANGIODYNAMICS INC (NASDAQ:ANGO) - AngioDynamics, Inc. designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat peripheral vascular disease, tumors, and other non-coronary diseases. It operates in three segments: Peripheral Vascular, Access, and Oncology/Surgery. The Peripheral Vascular segment offers and manages venous, angiographic, percutaneous transluminal angioplasty (PTA), drainage, thrombolytic, targeted renal therapy, micro access, and transjugular access product lines. Its venous products include VenaCure and Sotradecol products; angiographic product line comprises angiographic catheters, entry needles, guidewires, and fluid management products; PTA product line consists of PTA dilation balloon catheters, including WORKHORSE and PROFILER to open blocked blood vessels and dialysis access sites; drainage product line includes TOTAL ABSCESSION general drainage catheters; and thrombolytic product line comprises PULSE SPRAY, UNI FUSE, and SPEEDLYSER catheters. The Access segment provides and manages dialysis, port, and PICC product lines. Its dialysis product line includes dialysis catheters, which are marketed under the DuraMax, SCHON, EVENMORE, DURA-FLOW, SCHON XL, and LIFEJET F-16 brands. The Oncology/Surgery segment offers radio frequency ablation products, which include radiofrequency ablation (RFA) disposable electrodes, RF resection device, and RFA generators; embolization products; and NanoKnife products, based on the principles of Irreversible Electroporation. The company offers its products to interventional radiologists, vascular surgeons, and surgical oncologists through a direct sales force in the United States and through a combination of direct sales and distributor relationships internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Queensbury, New York.

The SqueezeTrigger database of approximately 1 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net